Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

513.12
-7.8800-1.51%
Post-market: 513.310.1900+0.04%19:30 EDT
Volume:415.57K
Turnover:215.18M
Market Cap:22.01B
PE:18.36
High:528.02
Open:523.23
Low:512.29
Close:521.00
52wk High:609.35
52wk Low:302.19
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.96
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.44
PE(LYR):18.42

Loading ...

United Therapeutics presents Phase 3 ADVANCE OUTCOMES ralinepag PAH trial data at ATS 2026

Reuters
·
May 11

Assessing United Therapeutics (UTHR) Valuation After A Strong Year Of Shareholder Returns

Simply Wall St.
·
May 10

United Therapeutics EVP, General Counsel Paul Mahon disposes 8,300 shares for $4.86 million

Reuters
·
May 08

United Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
May 08

United Therapeutics Growth Outlook Remains Supported by Tyvaso, Ralinepag, RBC Says

MT Newswires Live
·
May 08

RBC Capital Adjusts United Therapeutics Price Target to $701 From $707, Maintains Outperform Rating

MT Newswires Live
·
May 07

United Therapeutics Raised to Overweight From Equal-Weight by Wells Fargo

Dow Jones
·
May 07

BUZZ-MannKind falls after quarterly revenue miss

Reuters
·
May 07

Morgan Stanley Trims Price Target on United Therapeutics to $516 From $519, Keeps Equalweight Rating

MT Newswires Live
·
May 07

United Therapeutics reports Q1 EPS $5.82, consensus $6.86

TIPRANKS
·
May 07

United Therapeutics’ Earnings Call Signals Next Growth Phase

TIPRANKS
·
May 07

United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares worth $5.43 million

Reuters
·
May 07

MannKind Q1 revenue rises 15% but swings to net loss

Reuters
·
May 07

MannKind Buy Rating Reiterated as United Therapeutics Expands DPI Partnership; $8 Price Target Unchanged

TIPRANKS
·
May 07

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber

Reuters
·
May 06

United Therapeutics Q1 Earnings, Revenue Fall

MT Newswires Live
·
May 06

BUZZ-MannKind rises as it partners with United Therapeutics on inhaled drug for rare lung disease

Reuters
·
May 06

Earnings Flash (UTHR) United Therapeutics Posts Q1 EPS $5.82, vs. FactSet Est of $6.91

MT Newswires Live
·
May 06

MannKind Corp - Eligible for up to $35 Mln in Milestones and 10% Royalties on Net Sales

THOMSON REUTERS
·
May 06

MannKind Corp - Announces Development of Ralinepag Dry Powder Inhalation for United Therapeutics

THOMSON REUTERS
·
May 06